Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate for the damage, a study suggests.

Columnist Ben Hofmeister sometimes misuses the word "we." It usually means he wants to feel included in something.

Columnist Desiree Lama misses the summers when she wasn't dealing with MS and its associated heat intolerance.

If you’re nervous about traveling with MS, I hope my experience shows that it’s possible — and even enjoyable. Take your time ...

People who develop MS at a younger age tend to have better long-term physical health but worse mental health than those ...

Soon after initiating gender-affirming hormone therapy, seven of 10 adults with MS showed new signs of disease activity on ...

Gum disease caused by the bacteria Porphyromonas gingivalis is linked to worse multiple sclerosis (MS) in a mouse model of ...

An experimental medication boosted motor function in mice and primate models of multiple sclerosis by repairing the myelin ...

Ambio will test ibogaine, an experimental, naturally occurring psychedelic, as a therapy for neurodegenerative conditions such as MS.

Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.